Drug Pipeline

RYZ101 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05477576 Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET… GEP-NET Recruiting
Phase 1/2
NCT07150806 RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma Recurrent Meningioma Recruiting
NCT06590857 Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or… Metastatic Breast Cancer Active, Not Recruiting
Sponsors Running RYZ101 Trials
RayzeBio, Inc. (2) Joshua Palmer (1)
Disease Areas
Breast Cancer (1)
Get alerts when RYZ101 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free